HIV-1 gp160 induces transforming growth factor-β production in human PBMC

34Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Transforming growth factor-β (TGF-β) is a multifunctional cytokine secreted by many mononuclear cells in peripheral blood (PBMC) and has diverse effects on cellular and humoral immunity. Increased TGF-β mRNA expression has been reported in PBMC of HIV-infected patients, but the mechanism by which HIV induces TGF-β secretion is unknown. In this study, we observed that HIV gp160 could induce significant TGF-β secretion and TGF-β mRNA expression in PBMC from HIV-seronegative healthy donors. The cellular source of TGF-β was attributed to non-T cells, presumably monocytes. Specificity of secreted TGF-β was confirmed by the addition of anti-TGF-β mAb which abrogated the proliferative response of CCL-64 cells by gp160-treated culture supernatants. Soluble CD4 blocked the gp160-induced TGF-β production, suggesting that CD4-gp160 interaction is required to induce TGF-β production. Our results suggest that HIV-1 gp160 may contribute to the immune defects in HIV infection by inducing TGF-β secretion. © 1990 Academic Press, Inc.

Cite

CITATION STYLE

APA

Hu, R., Oyaizu, N., Than, S., Kalyanaraman, V. S., Wang, X. P., & Pahwa, S. (1996). HIV-1 gp160 induces transforming growth factor-β production in human PBMC. Clinical Immunology and Immunopathology, 80(3 II), 283–289. https://doi.org/10.1006/clin.1996.0125

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free